+
  • 8abfad95-7769-4b1d-8453-7fa422016728.jpg

Serogroup B Meningococcal Outer Membrane Vesicle Vaccine

Classification:

Products in the Pipeline


  • Product Description
  • Immunogenicity
  • Security
  • Mad Dog Bite Cases
  • Manufacturing Process

    It employs leading Outer-Membrane Vesicle (OMV) technology in China as an international cooperation project of CDBIO with the more advanced design and higher immunogenicity.

     

    Current Progress 

    In pre-clinical study.

Other Products

Inactivated Japanese Encephalitis Vaccine for Human Use (Vero cell) (IJEV)

SPEEDA-Rabies Vaccine for Human Use (Vero cell) (CPRV)

Rabies Vaccine (Human Diploid Cell) for Human Use, Freeze-dried (HDCV)

Influenza Vaccine (Split Virion), Inactivated, Quadrivalent (QIV)

13-valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV 13)

Recombinant Human Papillomavirus 15-valent Vaccine (Escherichia. Coli) (HPV 15)